Second-Line Endocrine Therapy With or Without Palbociclib Rechallenge in Patients With Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: PALMIRA Trial
Palbociclib rechallenge plus an alternative ET did not significantly improve PFS compared with ET alone in patients with hormone receptor-positive/HER2-negative ABC progressing on a first-line palbociclib-based ET regimen.
Authors
- Daniel Alcalá-López (ORCID: https://orcid.org/0000-0003-2184-1346)
- Sara Marín
- Antonia Perelló (ORCID: https://orcid.org/0000-0003-4137-8790)
- Adela Fernández-Ortega (ORCID: https://orcid.org/0000-0001-5921-0246)
- Catherine Harper‐Wynne (ORCID: https://orcid.org/0000-0002-8414-6722)
- Antonio Llombart‐Cussac (ORCID: https://orcid.org/0000-0003-4515-8293)
- Duncan Wheatley (ORCID: https://orcid.org/0000-0002-1919-5114)
- Jhudit Pérez‐Escuredo (ORCID: https://orcid.org/0009-0009-1691-1849)
- Javier Cortés (ORCID: https://orcid.org/0000-0001-7623-1583)
- Marco Colleoni (ORCID: https://orcid.org/0000-0002-5743-3013)
- Jacques Médioni (ORCID: https://orcid.org/0000-0003-1100-5264)
- Antonio Antón (ORCID: https://orcid.org/0000-0002-1925-4102)
- Manuel Ruíz-Borrego (ORCID: https://orcid.org/0000-0002-1181-5622)
- Vega Iranzo (ORCID: https://orcid.org/0000-0001-6183-5173)
- Audrey Hennequin (ORCID: https://orcid.org/0000-0001-8043-1836)
- Erion Dobi
- Miguel Sampayo-Cordero (ORCID: https://orcid.org/0000-0003-1469-3410)
- Sonia Del Barco (ORCID: https://orcid.org/0000-0002-4951-6871)
- Vanesa Quiroga (ORCID: https://orcid.org/0000-0002-7852-474X)
- Gabriele Antonarelli (ORCID: https://orcid.org/0000-0002-9758-3665)
- J. M. Perez-Garcia (ORCID: https://orcid.org/0009-0004-2204-2014)
Institutions
- Universitat de València (ES)
- University of Milan (IT)
- Université Paris Cité (FR)
- Universidad de Zaragoza (ES)
- Royal Cornwall Hospital Trust (GB)
- Universidad Cardenal Herrera CEU (ES)
- Maidstone Hospital (GB)
- Centre Georges François Leclerc (FR)
- Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (ES)
- Hôpital Européen Georges-Pompidou (FR)
- MedSIR (Spain) (ES)
- Institut Català d'Oncologia (ES)
- Hôpital Européen (FR)
- Hospital Universitario Miguel Servet (ES)
- Hospital Arnau de Vilanova (ES)
- Hôpital Privé Jean Mermo (FR)
- Hospital General Universitario De Valencia (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
- Hospital Universitario Son Espases (ES)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Hospital Universitario Virgen del Rocío (ES)
- European Institute of Oncology (IT)
- Universidad Europea de Madrid (ES)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2025-04-28
- DOI
- https://doi.org/10.1200/jco-24-01865
- Citations
- 10
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 15.18